MX2020006741A - Uso de oxigeno y oxido nitrico inhalado para el tratamiento de la hipertension pulmonar. - Google Patents

Uso de oxigeno y oxido nitrico inhalado para el tratamiento de la hipertension pulmonar.

Info

Publication number
MX2020006741A
MX2020006741A MX2020006741A MX2020006741A MX2020006741A MX 2020006741 A MX2020006741 A MX 2020006741A MX 2020006741 A MX2020006741 A MX 2020006741A MX 2020006741 A MX2020006741 A MX 2020006741A MX 2020006741 A MX2020006741 A MX 2020006741A
Authority
MX
Mexico
Prior art keywords
nitric oxide
pulmonary hypertension
oxygen
treatment
inhaled nitric
Prior art date
Application number
MX2020006741A
Other languages
English (en)
Inventor
Parag Shah
Deborah Quinn
Original Assignee
Bellerophon Pulse Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bellerophon Pulse Tech Llc filed Critical Bellerophon Pulse Tech Llc
Publication of MX2020006741A publication Critical patent/MX2020006741A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
    • A61M16/101—Preparation of respiratory gases or vapours with O2 features or with parameter measurement using an oxygen concentrator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/06—Respiratory or anaesthetic masks
    • A61M16/0666—Nasal cannulas or tubing
    • A61M16/0672—Nasal cannula assemblies for oxygen therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/0007—Special media to be introduced, removed or treated introduced into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0208—Oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/12—Blood circulatory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Otolaryngology (AREA)

Abstract

Se describen en la presente métodos para el uso de óxido nítrico inhalado para el tratamiento de la hipertensión pulmonar, la mejora de la capacidad de ejercicio y/o la reducción de la de saturación de oxígeno en un paciente.
MX2020006741A 2017-12-28 2018-12-28 Uso de oxigeno y oxido nitrico inhalado para el tratamiento de la hipertension pulmonar. MX2020006741A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762611316P 2017-12-28 2017-12-28
PCT/US2018/067793 WO2019133776A1 (en) 2017-12-28 2018-12-28 Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension

Publications (1)

Publication Number Publication Date
MX2020006741A true MX2020006741A (es) 2020-11-24

Family

ID=67068194

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020006741A MX2020006741A (es) 2017-12-28 2018-12-28 Uso de oxigeno y oxido nitrico inhalado para el tratamiento de la hipertension pulmonar.

Country Status (15)

Country Link
US (1) US12653837B2 (es)
EP (1) EP3731913A4 (es)
JP (1) JP2021509108A (es)
KR (2) KR20200127157A (es)
CN (2) CN120114475A (es)
AU (2) AU2018394928B2 (es)
BR (1) BR112020012964A2 (es)
CA (1) CA3087195A1 (es)
EA (1) EA202091286A1 (es)
IL (1) IL275678A (es)
MX (1) MX2020006741A (es)
PH (1) PH12020550978A1 (es)
SG (1) SG11202005974YA (es)
TW (1) TW201929841A (es)
WO (1) WO2019133776A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019009931A (es) 2017-02-27 2020-07-14 Third Pole Inc Sistemas y metodos para generacion ambulatoria de oxido nitrico.
JP6704094B2 (ja) 2017-02-27 2020-06-03 サード ポール, インコーポレイテッドThird Pole, Inc. 酸化窒素を生成するためのシステムおよび方法
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
TW202021637A (zh) * 2018-08-10 2020-06-16 美商貝勒羅豐治療公司 吸入性一氧化氮（ｉＮＯ）用於改善嚴重低血氧症之用途
WO2020142658A1 (en) * 2019-01-04 2020-07-09 Bellerophon Therapeutics Use of inhaled nitric oxide (ino) for improving activity levels in patients with lung-related conditions
EP3969415A4 (en) 2019-05-15 2023-08-16 Third Pole, Inc. ELECTRODES FOR GENERATING NITROUS OXIDE
WO2020232414A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Architectures for production of nitric oxide
WO2020232419A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Systems and methods for generating nitric oxide
EP4069069A4 (en) 2020-01-11 2024-07-03 Third Pole, Inc. SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL
US20230067942A1 (en) * 2020-01-31 2023-03-02 Bellerophon Therapeutics IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENT
AU2021281427A1 (en) * 2020-05-29 2023-02-02 Mallinckrodt Pharmaceuticals Ireland Limited Method for pulsatile delivery of a gaseous drug
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
WO2022082072A1 (en) 2020-10-16 2022-04-21 Third Pole, Inc. Nitric oxide generation process controls
WO2023049873A1 (en) 2021-09-23 2023-03-30 Third Pole, Inc. Systems and methods for delivering nitric oxide
US12569628B2 (en) 2022-04-14 2026-03-10 Third Pole, Inc. Delivery of medicinal gas in a liquid medium

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9216239B2 (en) * 2001-06-08 2015-12-22 Leo Rubin Medical device for intra-lumenal delivery of pharmaceutical agents
JP2010512414A (ja) * 2006-12-12 2010-04-22 ギリード・コロラド・インコーポレーテッド 肺高血圧を処置するための組成物
WO2015148169A1 (en) * 2014-03-28 2015-10-01 Shape Medical Systems, Inc. Pattern recognition system for quantifying the likelihood of the contribution of multiple possible forms of chronic disease to patient reported dyspnea
US20170165294A1 (en) * 2015-12-11 2017-06-15 Geno Llc Method and apparatus for administering gases including nitric oxide to address fibrosis
EP3397331A4 (en) * 2015-12-28 2019-08-21 Vero Biotech LLC METHOD AND APPARATUS FOR ADMINISTERING NITRIC OXIDE WITH ADDITIONAL MEDICAMENTS
PT3970730T (pt) * 2016-02-12 2024-07-30 Mallinckrodt Pharmaceuticals Ireland Ltd Sistema para utilização e monitorização de óxido nítrico inalado com dispositivos de ajuda ventricular esquerda

Also Published As

Publication number Publication date
CN120114475A (zh) 2025-06-10
JP2021509108A (ja) 2021-03-18
SG11202005974YA (en) 2020-07-29
KR20240125694A (ko) 2024-08-19
KR20200127157A (ko) 2020-11-10
WO2019133776A1 (en) 2019-07-04
AU2025202796A1 (en) 2025-05-08
TW201929841A (zh) 2019-08-01
US12653837B2 (en) 2026-06-16
IL275678A (en) 2020-08-31
US20200360425A1 (en) 2020-11-19
BR112020012964A2 (pt) 2020-12-01
CN111867664A (zh) 2020-10-30
EP3731913A4 (en) 2021-09-01
AU2018394928A1 (en) 2020-07-02
CA3087195A1 (en) 2019-07-04
AU2018394928B2 (en) 2025-01-23
EA202091286A1 (ru) 2020-11-05
EP3731913A1 (en) 2020-11-04
PH12020550978A1 (en) 2021-04-19

Similar Documents

Publication Publication Date Title
PH12020550978A1 (en) Use of inhaled nitric oxide and oxygen for the treatment of pulmonary hypertension
MX2025004666A (es) Uso de oxido nitrico inhalado para el tratamiento de la hipertension pulmonar asociada con enfermedades pulmonares
PH12019501575A1 (en) ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF
PH12020550979A1 (en) Pulsed administration of inhaled nitric oxide for the treatment of pulmonary hypertension
PH12017502154A1 (en) Methods for conditioning patients for t cell therapy
MX2021008007A (es) Uso del oxido nitrico inhalado (ino) para mejorar los niveles de actividad en pacientes con afecciones relacionadas con el pulmon.
PH12017502103A1 (en) Methods and kits for treating depression
MX2016005532A (es) Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades.
MX2025005908A (es) Terapias de farmaco de combinacion de inhibidores de fosfodiesterasa tipo 5 (pde-5) y oxido nitrico inhalado
NZ755166A (en) Biofilm disrupting composition for use on chronic wounds
SG10201902594QA (en) Peptidomimetic macrocycles and uses thereof
MX2025003477A (es) Uso de reboxetina para el tratamiento de narcolepsia
MX2018010223A (es) Terapia combinada para tratamiento de cancer de ovario.
PH12017501300A1 (en) Novel iodophor composition and methods of use
PH12017500392A1 (en) Medical treatments based on anamorelin
MX2022008786A (es) Mejora en la distensibilidad arterial pulmonar con tratamiento de oxido nitrico inhalado (ino).
TW201613544A (en) Treatment device and chair
MX2020011738A (es) Uso de calcifediol en pacientes de cirugia bariatrica.
EP4385576A3 (en) Use of 2-hydroxybenzylamine in the treatment and prevention of pulmonary hypertension
ZA202002107B (en) Use of specific sirna against protein s for the treatment of hemophilia
EA202090151A1 (ru) Применение вдыхаемого оксида азота (ii) для лечения легочной гипертензии, связанной с заболеванием легких
ZA202210311B (en) Coronavirus therapeutics and treatment methods
TR201914615A2 (tr) Fistül ve hemoroid tedavisinde kullanılmak üzere karboksiterapi kullanımı.
MX2017011838A (es) Composiciones y metodos para tratar carcinoma hepatocelular.
UA87586U (uk) Спосіб лікування гострої респіраторної вірусної інфекції у вагітних